The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype.
Bertucci, François
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype. [electronic resource] - NPJ breast cancer 2020 - 8 p. digital
Publication Type: Journal Article
2374-4677
10.1038/s41523-020-0151-5 doi
The therapeutic response of ER+/HER2- breast cancers differs according to the molecular Basal or Luminal subtype. [electronic resource] - NPJ breast cancer 2020 - 8 p. digital
Publication Type: Journal Article
2374-4677
10.1038/s41523-020-0151-5 doi